Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON52035
NL-OMON52035
Completed
Not Applicable

Multiple sclerosis lesion characterization on ultra-high-field MRI: Comparative pilot study of 9.4 vs 7 vs 3 tesla - ULTIMS

Zuyderland Medisch Centrum0 sites10 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsMSmultiple sclerosis10012303

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
MS
Sponsor
Zuyderland Medisch Centrum
Enrollment
10
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational non invasive

Investigators

Sponsor
Zuyderland Medisch Centrum

Eligibility Criteria

Inclusion Criteria

  • •Relapsing remitting MS patients (according to the 2017
  • •McDonald criteria) between age 18\-65 years, who had a new brain MRI lesion in
  • •the past 15 months. Choosing an upper limit of 65 years, limits the age\-related
  • •vascular white matter lesion burden on the brain scans.

Exclusion Criteria

  • •Patients who are unable to undergo MRI investigations due to (i) non\-compatible
  • •implanted material/devices or (ii) due to not being able to lie flat long
  • •enough because of another medical condition, will be excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
Characterisation of multiple sclerosis pathology by ultra small particles of iron oxide (USPIO)” in comparison with conventional and advanced MRI imaging techniques[Charakterisierung der Multiple Sklerose Pathologie durch ultra small particles of iron oxide (USPIO)” im Vergleich zu konventionellen und fortgeschrittenen MRT Techniken] - MS_USPIO_MPIPPatients with Multiple Sclerosis (MS, N=90) and patients with a clinically isolated syndrome (ref. to as CIS in literature, i. e. not a clinically definite MS but a syndrome that may occur as first sign of MS early in the course, N=15) are planned to be investigated in the proposed clinical trial.MedDRA version: 8.1Level: LLTClassification code 10028245Term: Multiple sclerosis
EUCTR2006-001337-17-DEMax-Planck-Institute of Psychiatry
Completed
Not Applicable
Diagnostic criteria for Multiple Sclerosis: Impact of high field Magnetic Resonance ImagingMSmultiple sclerosis1000381610012303
NL-OMON40083Vrije Universiteit Medisch Centrum30
Active, not recruiting
Not Applicable
Ultra-high-field Brain MRI in Multiple SclerosisMultiple Sclerosis
NCT05718947Zuyderland Medisch Centrum10
Completed
Not Applicable
Proxy measurements in Multiple SclerosisMultiple Sclerosis10029317
NL-OMON31939Vrije Universiteit Medisch Centrum300
Active, not recruiting
Not Applicable
Identifying genetic determinants of outcome in multiple sclerosisMultiple sclerosisNervous System Diseases
ISRCTN41688895Cambridge University Hospitals NHS Foundation Trust10,000